Acro Biomedical Co., Ltd. (ACBM)

Market Cap	1.56M -98.9%
Revenue (ttm)	n/a
Net Income	-134.62K
EPS	-0.00
Shares Out	60.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260
Open	0.0260
Previous Close	n/a
Day's Range	0.0260 - 0.0260
52-Week Range	0.0222 - 0.1000
Beta	-2.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Acro Biomedical

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

• Industry: Shell Companies
• Sector: Financials
• Founded: 2014
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACBM

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 17, 2026

Data Sources Report a data error